0001179110-19-011796.txt : 20191118
0001179110-19-011796.hdr.sgml : 20191118
20191118173304
ACCESSION NUMBER: 0001179110-19-011796
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191114
FILED AS OF DATE: 20191118
DATE AS OF CHANGE: 20191118
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: JOHNSON JOHN
CENTRAL INDEX KEY: 0001410781
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37569
FILM NUMBER: 191228492
MAIL ADDRESS:
STREET 1: DENDREON CORPORATION
STREET 2: 1301 2ND AVENUE
CITY: SEATTLE
STATE: WA
ZIP: 98101
FORMER NAME:
FORMER CONFORMED NAME: Johnson John H
DATE OF NAME CHANGE: 20070827
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Strongbridge Biopharma plc
CENTRAL INDEX KEY: 0001634432
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981130690
STATE OF INCORPORATION: L2
BUSINESS ADDRESS:
STREET 1: 900 NORTHBROOK DRIVE, SUITE 200
CITY: TREVOSE
STATE: PA
ZIP: 19053
BUSINESS PHONE: (610) 254-9200
MAIL ADDRESS:
STREET 1: 900 NORTHBROOK DRIVE, SUITE 200
CITY: TREVOSE
STATE: PA
ZIP: 19053
FORMER COMPANY:
FORMER CONFORMED NAME: Cortendo AB
DATE OF NAME CHANGE: 20150219
4
1
edgar.xml
FORM 4 -
X0306
4
2019-11-14
0
0001634432
Strongbridge Biopharma plc
SBBP
0001410781
JOHNSON JOHN
900 NORTHBROOK DRIVE
SUITE 200
TREVOSE
PA
19053
1
1
0
0
Executive Chairman
Employee Stock Option (right to buy)
1.56
2019-11-14
4
A
0
275000
0
A
2029-11-14
Common Stock
275000
275000
D
Granted in connection with the Reporting Person's appointment as executive chairman of the Issuer.
This option vests in sixteen equal quarterly installments beginning February 14, 2020, provided the Reporting Person is employed by or serving as a director of the Issuer on each vesting date.
/s/ Stephen J. Long, as attorney-in-fact
2019-11-18